<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03920332</url>
  </required_header>
  <id_info>
    <org_study_id>CCER2019-00353</org_study_id>
    <nct_id>NCT03920332</nct_id>
  </id_info>
  <brief_title>Pregnancy and Fibrinogen Disorders</brief_title>
  <acronym>FIBRINOGEST</acronym>
  <official_title>Obstetric Outcomes of Women Suffering From Hereditary Fibrinogen Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss Hemophilia Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this observational study is to evaluate the prevalence of uncomplicated
      pregnancies in women suffering from congenital fibrinogen disorders (i.e, hypofibrinogenemia,
      dysfibrinogenemia, hypodysfibrinogenemia) as well as to describe pregnancies outcomes in such
      diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women with quantitative or qualitative fibrinogen disorders are often more prone to
      obstetrical complications, from bleeding to recurrent miscarriages or thrombosis. Data on
      fibrinogen levels variations throughout the pregnancy and on the delivery management are
      lacking. In this observational study will be include adult women with pas obstetrical
      history. A general questionnaire on demographics and clinical data will be filled out by the
      patient's physician. A detailed questionnaire on obstetrical data will also be completed
      contacting the patient in case of lacking data.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of normal issue pregnancy</measure>
    <time_frame>At inclusion</time_frame>
    <description>All pregnancy not resulting in miscarriage, stillbirth or abortion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of pregnancy without complications</measure>
    <time_frame>At inclusion</time_frame>
    <description>All pregnancy not resulting in intrauterine growth retardation, preterm labor, pregnancy-induced hypertension, gestational diabetes, preeclampsia, abruption placenta, anamniota, vaginal bleeding requiring medical intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modalities of delivery</measure>
    <time_frame>At inclusion</time_frame>
    <description>Vaginal versus caesarean cut</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modalities of delivery</measure>
    <time_frame>At inclusion</time_frame>
    <description>Instrumental delivery vs none</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-partum complications</measure>
    <time_frame>At inclusion</time_frame>
    <description>Post-partum haemorrhage and/or thrombotic event within 3 months after the delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibrinogen variations</measure>
    <time_frame>At inclusion</time_frame>
    <description>Fibrinogen levels throughout the pregnancy</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hypofibrinogenemia, Congenital</condition>
  <condition>Afibrinogenemia, Congenital</condition>
  <condition>Dysfibrinogenemia, Congenital</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Women will be recruited in Hemophilia Centers.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inherited fibrinogen disorders (hypofibrinogenemia, dysfibrinogenemia,
             hypodysfibrinogenemia)

          -  At lest one past pregnancy

          -  Adult

        Exclusion Criteria:

          -  No past pregnancy

          -  Not confirmed fibrinogen disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessandro Casini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals of Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Justine Hugon-Rodin, MD, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alessandro Casini, MD</last_name>
    <phone>+41223729757</phone>
    <email>alessandro.casini@hcuge.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Port-Royal</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Justine Hugon-Rodin, MD, PHD</last_name>
      <phone>+33158413550</phone>
      <email>justine.hugon-rodin@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jessenius Faculty of Medicine and University Hospital</name>
      <address>
        <city>Martin</city>
        <zip>03659</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomas Simurda, MD PHD</last_name>
      <phone>+421434203232</phone>
      <email>tomas.simurda@uniba.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospitals of Geneva</name>
      <address>
        <city>Geneva</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Casini, MD</last_name>
      <phone>+41223729757</phone>
      <email>alessandro.casini@hcuge.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Slovakia</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>April 12, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2019</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Casini Alessandro</investigator_full_name>
    <investigator_title>MD, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>obstetric</keyword>
  <keyword>miscarriage</keyword>
  <keyword>haemorrhage</keyword>
  <keyword>fibrinogen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Afibrinogenemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

